Investment Thesis

.

Competitive Moat

ResMed enjoys a strong competitive moat characterized by intangible assets, including proprietary technology and a well-established brand reputation in the sleep and respiratory care markets. Its cloud-based solutions create network effects by enhancing patient engagement and compliance, making it difficult for new entrants to compete effectively. This advantage is expected to remain durable over the next 5-10 years, although competition from companies like Philips and Medtronic poses significant threats in the high-demand respiratory device sector.

Growth Engine

Future revenue growth for ResMed is driven by the expanding total addressable market (TAM) for sleep apnea treatment, projected to reach $60 billion by 2025, as well as increasing adoption of its innovative SaaS offerings. The company's focus on geographic expansion, particularly in emerging markets, complements its organic growth strategy, which has been further bolstered through targeted acquisitions in the digital health space. ResMed is gaining market share as it enhances its product portfolio and engages more effectively with healthcare providers.